Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab

التفاصيل البيبلوغرافية
العنوان:	Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab
المؤلفون:	Delea, Thomas E., Tappenden, Paul, Sofrygin, Oleg, Browning, Dominy, Amonkar, Mayur M., Karnon, Jon, Walker, Mel D., Cameron, David
المصدر:	The European Journal of Health Economics, 2012 Oct 01. 13(5), 589-603.
الوصول الحر:	https://www.jstor.org/stable/23275635Test
قاعدة البيانات:	JSTOR Journals

الوصف
تدمد:	16187598 16187601